Abstract
A regioselective cycloaddition reaction of arenediazonium salts with trimethylsilyldiazomethane is reported. A series of 2-aryltetrazoles were obtained in good to moderate yields with wide functional group compatibility. Furthermore, this cycloaddition reaction opens the way to build up the versatile intermediate 2-aryl-5-bromotetrazole.
Keywords: [3+2] Cycloaddition, Silver catalysis, Trimethylsilyldiazomethane, 2H-Tetrazole
Graphical abstract
![]()
Introduction
Tetrazoles are an important class of five-membered ring heterocycles broadly used in pharmaceuticals, agrochemicals and material science. Surprisingly, the synthesis of simple unsubstituted 2-aryltetrazoles is almost non-existent in the literature. Lippmann et al. has developed a regioselective method for the construction of 2-aryl tetrazoles employing 2-(2-arylhydrazono)acetic acid and 1-azido-2,4,6-tribromobenzene1. Ito’s synthesis employs arylsulfonylhydrazones and arene diazonium salts but both of these strategies afford 2-aryl-5-carboxylatetetrazole and must be decarboxylated at 160 °C2. Genin et al. and Kitazaki et al. reported a nucleophilic aromatic substitution between 4-nitrofluorobenzene or 3,4-difluoronitrobenzene and tetrazole but these non-regioselective transformations gave poor yields and require the nitro group for activation (10% to 25%)3,4. Very recently, Ramanathan et al. reported a cyclisation between an aryldiazonium salt and formamidine in the presence of iodide5.
There are more examples of 2-aryl-5-substituted tetrazoles in the primary literature. This scaffold has recently acquired increasing attention from the medicinal chemistry community. For example, this substitution pattern has recently appeared in Breast Cancer Resistance Protein inhibitors6, DNA methyltransferases 1 inhibitors7, α4β2α5 nicotinic acetylcholine receptors modulators8, FAAH inhibitors9 and MDR1 inhibitors10. In addition to Lippmann’s and Ito’s synthetic methods, Han and co-workers reported the synthesis of 2-aryl-5-substituted tetrazoles through the coupling of 5-substituted tetrazoles with arylboronic acids in the presence of copper(II)11. Onaka et al. also reported a regioselective 2-arylation of 5-substituted tetrazoles catalyzed by [Cu(OH)(TMEDA)]2Cl2.12
We recently had the need for the synthesis of substituted N-linked tetrazoles with versatility for substitution at the 5-position (H or aryl) wherein none of the current published methods proved useful. Therefore we embarked upon a search for a facile and robust method to generate these molecules. Chen et al. recently reported a cycloaddition between an arene-diazonium salt and 2,2,2-trifluorodiazoethane with a catalytic amount of silver salt13. This method was attractive, however the tetrazole products formed were CF3-substituted at the 5-position wherein we needed a hydrogen atom or aryl ring. We envisioned that a silver salt might also be utilized to promote the cyclization of an arenediazonium salt with trimethylsilyldiazomethane. This would provide for TMS-substituted tetrazoles, which could either be desilylated to produce the unsubstituted tetrazole or converted to the bromo-tetrazole for further functionalization (Figure 1). Herein, we report a [3+2] cycloaddition between an arenediazonium salt and trimethylsilyldiazomethane with a silver salt catalyst. This cycloaddition affords 2-aryl-5-trimethylsilyltetrazoles, a key intermediate which can be easily cleaved in one pot with CsF to provide 2-aryltetrazoles.
Figure 1.

Tetrazole Formation
Results and discussion
To optimize reaction conditions, phenyl diazonium tetrafluoroborate 1a was employed as a substrate using trimethylsilyldiazomethane with various silver salts and one copper salt (widely used in click chemistry) in THF at −78 °C (entries 1–7, Table 1). To our delight, CF3CO2Ag was found to be optimal, and the cycloaddition proceeded smoothly to furnish the desired cycloadduct 2a in 75% yield (entry 1).
Table 1.
Optimization of reaction conditionsa
| ||||
|---|---|---|---|---|
| Entry | Catalyst | Base (equiv) | Solvent | Yieldb (%) |
| 1 | CF3CO2Ag | Et3N(1.5) | THF | 82 (75) |
| 2 | AgBF4 | Et3N(1.5) | THF | 70(61) |
| 3 | AgNO3 | Et3N(1.5) | THF | 69 |
| 4 | AgOTf | Et3N(1.5) | THF | 70 (62) |
| 5 | AgOAc | Et3N(1.5) | THF | 42 |
| 6 | Ag2CO3 | Et3N(1.5) | THF | <10 |
| 7 | Cu(OAc)2 | Et3N(1.5) | THF | <10 |
| 8 | CF3CO2Ag | Cs2CO3(1.5) | THF | 36 |
| 9 | CF3CO2Ag | Na2CO3(1.5) | THF | <10 |
| 10 | CF3CO2Ag | Lutidine (1.5) | THF | <10 |
| 11 | CF3CO2Ag | DBU(1.5) | THF | 71 |
| 12 | CF3CO2Ag | DABCO (2.0) | THF | 49 |
| 13 | CF3CO2Ag | Et3N (2.0) | THF | 79 |
| 14 | CF3CO2Ag | Et3N(2.5) | THF | 74 |
| 15b | CF3CO2Ag | Et3N (3.0) | THF | 77 |
| 16c | CF3CO2Ag | Et3N (3.0) | THF | 79 |
| 17d | CF3CO2Ag | Et3N(1.5) | THF | <10 |
| 18e | CF3CO2Ag | Et3N(1.5) | THF | <10 |
| 19f | CF3CO2Ag | Et3N(1.5) | THF | 23 |
| 20 | CF3CO2Ag | Et3N(1.0) | THF | 54 |
| 21 | — | Et3N(1.5) | THF | <10 |
| 22 | CF3CO2Ag | — | THF | <10 |
| 23 | CF3CO2Ag | Et3N(1.5) | CH3CN | <10 |
| 24 | CF3CO2Ag | Et3N(1.5) | DCM | <10 |
| 25 | CF3CO2Ag | Et3N(1.5) | DMF | <10 |
| 26g | CF3CO2Ag | Et3N(1.5) | THF/DMF | 23 |
| 27 | CF3CO2Ag | Et3N(1.5) | Toluene | 77 (69) |
General reaction conditions: 1a (0.2 mmol), Me3SiCHN2 (1.1eq), catalyst (1.2 eq), base (x equiv) in 2 mL of solvent under Ar at −78°C for 1 h. Yields were determined by HPLC with 3,5-Dimethoxybromobenzene as an internal standard. The values in parentheses represent the yields of isolated products.
2 eq CF3CO2Ag;
2 eq CF3CO2Ag and 1.5 eq Me3 SiCHN2;
10 mol% of CF3CO2 Ag was used;
reaction at 4°C;
reaction at −20°C;
THF/DMF = 10/1.
The use of 2 equivalents of CF3CO2Ag did not improve the yield (entries 15 and 16). In sharp contrast, the reaction did not proceed without the silver catalyst or with only 10 mol% of CF3CO2Ag (entries 17 and 21). The control of the temperature is a critical parameter: a mixture of uncharacterized by-products is obtained when the reaction is conducted at 4°C and poor yield was obtained at −20°C (entries 18 and 19). Note that 1-aryl-1H-Tetrazole has never been detected. Next, we turned our attention to testing a range of mineral and organic bases. Triethylamine was found to be the base of choice for this cycloaddition reaction (entries 8–12). The yield substantially decreased with only 1 equivalent of trimethylamine (entry 20) and no reaction was observed without any base (entry 21), but 2.0 equivalents of Et3N did not improve the yield when compared to that obtained with 1.5 equivalent of Et3N (entries 1 and 13). A solvent screen was conducted in order to explore this parameter further (entries 23–27). THF was identified as the optimal solvent from those screened.
Having established optimal conditions, we set out to explore the scope of this silver-mediated cycloaddition reaction, and the results are summarized in Scheme 1. In the case of phenyl diazonium salts, the cycloaddition reaction tolerates various substitution patterns and a range of different substituents on the phenyl ring. Alkyl-, alkoxy-, amino-, cyano-, nitro-, acid-, halo- and phenyl-substituted phenyldiazonium salts all undergo the desired reaction to give the cycloadducts 2a–l in moderate to good yields. It is worth noting that anilines bearing a free phenol group (2h) or carboxylic acid (2g) are tolerated as are electron poor (2c,2e–f,2m) or electron rich (2d,2h–i,k) aromatics. Note that in these reactions, only the 2-aryl tetrazole was formed and the 1-aryltetrazole was not observed.
Scheme 1.

Substrate scope of cycloaddition reaction of TMSCHN2 with aryl diazonium salts
To be synthetically useful, this new method also needed to scale well. Hence we conducted this reaction sequence on a 1g scale. As shown in Scheme 2, the diazotation step from the commercial aniline afforded 1k in 91% yield which does not require purification. Intermediate 1k reacted with TMSCHN2 to give the corresponding 2-substituted tetrazole 2k with a 67% yield in two steps.
Scheme 2.

Gram scale reaction
Finally, we turned our attention to the key intermediate 2-aryl-5-trimethylsilyl tetrazole (3k, Scheme 3). This reaction could be carried out without the addition of CsF and, under these conditions, we were able to isolate the trimethylsilyl derivate 3k in good yield. With this compound in hand, we demonstrated the versatile properties by substitution of the trimethylsilyl group with a bromine on the 5-position to afford 4k. From this compound, introduction of many other groups and functionalities are possible via metal-mediated coupling reactions. This route offers an approach for rapid structure-activity relationship studies (SAR) of the 5-position of the tetrazole ring. This strategy complements that of Ramanathan et al. and offers a new synthetic method for the synthesis of functionalized tetrazoles.
Scheme 3.

Access to the 2-aryl-5-bromo-tetrazole
Conclusions
In summary, we have successfully disclosed a quick and general method to synthesize 2-aryltetrazoles by a [3+2] regioseletive cycloaddition reaction of trimethylsilyldiazomethane with various aryl and heteroaryl diazonium salts. A broad range of 2-substituted tetrazoles were obtained in moderate to good yields. The practicality of this methodology was further demonstrated by the facile synthesis of a gram scale sequence. We believe this motif has the potential for use in drug discovery programs as a valuable synthetic building block, which is now readily available via this methodology.
Supplementary Material
Research highlights.
-
►
Regioselective cycloaddition reaction of arenediazonium salts with trimethylsilyldiazomethane.
-
►
Best catalyst to perform this reaction was silver trifluoroacetate.
-
►
A large set of diazonium salt was used under optimized conditions.
-
►
Gram scale have been successfully accomplished
Acknowledgments
The authors thank Dr. Xiaohai Li for performing HRMS (Grant 1S10OD010603-01A1). T.M.K. received funding from the National Institutes of Health, National Institute on Drug Abuse Grant P01DA033622.
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Supplementary data
Supplementary data associated with this article can be found in the online version, at.
References and notes
- 1.Lippmann E, Konnecke A, Beyer G. Monatsh Chem. 1975;106:437–442. [Google Scholar]
- 2.Ito S, Tanaka Y, Kakehi A, Kondo K. Bull Chem Soc Jpn. 1976;49:1920–1923. [Google Scholar]
- 3.Genin MJ, Allwine DA, Anderson DJ, Barbachyn MR, Emmert DE, Garmon SA, Graber DR, Grega KC, Hester JB, Hutchinson DK, Morris J, Reischer RJ, Ford CW, Zurenko GE, Hamel JC, Schaadt RD, Stapert D, Yagi BH. J Med Chem. 2000;43:953–970. doi: 10.1021/jm990373e. [DOI] [PubMed] [Google Scholar]
- 4.Kitazaki T, Ichikawa T, Tasaka A, Hosono H, Matsushita Y, Hayashi R, Okonogi K, Itoh K. Chem Pharm Bull. 2000;48(12):1935–1946. doi: 10.1248/cpb.48.1935. [DOI] [PubMed] [Google Scholar]
- 5.Ramanathan M, Wang YH, Liu ST. Org Lett. 2015:5886–5889. doi: 10.1021/acs.orglett.5b03068. [DOI] [PubMed] [Google Scholar]
- 6.Kohler S-C, Wiese M. J Med Chem. 2015;58:3910–3921. doi: 10.1021/acs.jmedchem.5b00188. [DOI] [PubMed] [Google Scholar]
- 7.Zhu B, Ge J, Yao SQ. Bioorg Med Chem. 2015;23:2917–2927. doi: 10.1016/j.bmc.2015.03.006. [DOI] [PubMed] [Google Scholar]
- 8.Jin Z, Khan P, Shin Y, Wang J, Lin L, Cameron M-D, Lindstrom JM, Kenny PJ, Kamenecka TM. Bioorg Med Chem Let. 2014;24:674–678. doi: 10.1016/j.bmcl.2013.11.049. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Garfunkle J, Ezzili C, Rayl T-J, Hochstatter DG, Hwang I, Boger DL. J Med Chem. 2008;51:4392–4403. doi: 10.1021/jm800136b. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Sprachman MM, Laughney AM, Kohler RH, Weissleder R. Bioconjugate Chem. 2014;25:1137–1142. doi: 10.1021/bc500154c. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.(a) Li Y, Gao LX, Han FS. Chem Commun. 2012;48:2719–2721. doi: 10.1039/c2cc17894j. [DOI] [PubMed] [Google Scholar]; (b) Liu CY, Li Y, Ding JY, Dong DW, Han FS. Chem-Eur J. 2014;20:2373–2381. doi: 10.1002/chem.201302857. [DOI] [PubMed] [Google Scholar]
- 12.Onaka T, Umemoto H, Miki Y, Nakamura A, Maegawa T. J Org Chem. 2014;79:6703–6707. doi: 10.1021/jo500862t. [DOI] [PubMed] [Google Scholar]
- 13.Chen Z, Fan SQ, Zheng Y, Ma JA. Chem Commun. 2015;51:16545–16548. doi: 10.1039/c5cc07324c. [DOI] [PubMed] [Google Scholar]
- 14.Zhang K, Xu XH, Qing FL. J Org Chem. 2015;80:7658–7665. doi: 10.1021/acs.joc.5b01295. [DOI] [PubMed] [Google Scholar]
- 15.Huisgen R, Fliege W, Kolbeck W. Chem Ber. 1983;116(9):3027–3038. [Google Scholar]
- 16.Nishiyama K, Oba M, Watanabe A. Tetrahedron. 1987;43(4):693–700. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
